The potential of translational bioinformatics approaches for pharmacology research.

The field of bioinformatics has allowed the interpretation of massive amounts of biological data, ushering in the era of 'omics' to biomedical research. Its potential impact on pharmacology research is enormous and it has shown some emerging successes. A full realization of this potential, however, requires standardized data annotation for large health record databases and molecular data resources. Improved standardization will further stimulate the development of system pharmacology models, using translational bioinformatics methods. This new translational bioinformatics paradigm is highly complementary to current pharmacological research fields, such as personalized medicine, pharmacoepidemiology and drug discovery. In this review, I illustrate the application of transformational bioinformatics to research in numerous pharmacology subdisciplines.

[1]  Ryen W. White,et al.  Web-scale pharmacovigilance: listening to signals from the crowd , 2013, J. Am. Medical Informatics Assoc..

[2]  Yang Xiang,et al.  Efficiently mining Adverse Event Reporting System for multiple drug interactions , 2014, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

[3]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[4]  Fergus J Couch,et al.  Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Adrian Benton,et al.  Online discussion of drug side effects and discontinuation among breast cancer survivors , 2013, Pharmacoepidemiology and drug safety.

[6]  P Ryan,et al.  Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.

[7]  E. Shapiro,et al.  Single-cell sequencing-based technologies will revolutionize whole-organism science , 2013, Nature Reviews Genetics.

[8]  Melissa A. Basford,et al.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. , 2010, American journal of human genetics.

[9]  A. Butte,et al.  Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data , 2011, Clinical pharmacology and therapeutics.

[10]  Russ B. Altman,et al.  Discovery and Explanation of Drug-Drug Interactions via Text Mining , 2011, Pacific Symposium on Biocomputing.

[11]  Hua Xu,et al.  Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin , 2011, J. Am. Medical Informatics Assoc..

[12]  Xu Han,et al.  Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions , 2012, PLoS Comput. Biol..

[13]  B D Athey,et al.  Needs for an Expanded Ontology‐Based Classification of Adverse Drug Reactions and Related Mechanisms , 2012, Clinical pharmacology and therapeutics.

[14]  S Sarntivijai,et al.  Use of Internet Search Logs to Evaluate Potential Drug Adverse Events , 2014, Clinical pharmacology and therapeutics.

[15]  Russ B. Altman,et al.  Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text , 2009, BMC Bioinformatics.

[16]  Melissa A. Basford,et al.  Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.

[17]  Xu Han,et al.  An integrated pharmacokinetics ontology and corpus for text mining , 2013, BMC Bioinformatics.

[18]  Michael Q. Zhang,et al.  Network-based global inference of human disease genes , 2008, Molecular systems biology.

[19]  D. Madigan,et al.  Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership , 2012, Statistics in medicine.

[20]  Xiaoyan Wang,et al.  Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. , 2009, Journal of the American Medical Informatics Association : JAMIA.

[21]  R. Altman,et al.  Personal Genomic Measurements: The Opportunity for Information Integration , 2013, Clinical pharmacology and therapeutics.

[22]  Carol Friedman,et al.  Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System. , 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[23]  Lang Li,et al.  Exploring a structural protein-drug interactome for new therapeutics in lung cancer. , 2014, Molecular bioSystems.

[24]  W. Bilker,et al.  Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins. , 2014, British journal of clinical pharmacology.

[25]  S. Gabriel,et al.  Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.

[26]  J. Overhage,et al.  Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership , 2010, Annals of Internal Medicine.

[27]  R. Altman,et al.  Integrating systems biology sources illuminates drug action , 2014, Clinical pharmacology and therapeutics.

[28]  Cui Tao,et al.  OAE: The Ontology of Adverse Events , 2014, J. Biomed. Semant..

[29]  R. Altman.  Translational Bioinformatics: Linking the Molecular World to the Clinical World , 2012, Clinical pharmacology and therapeutics.

[30]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[31]  Bo Zhang,et al.  A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge-Gen-Qin-Lian Decoction for Treatment of Type 2 Diabetes , 2014, Evidence-based complementary and alternative medicine : eCAM.

[32]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[33]  Roded Sharan,et al.  Large-Scale Elucidation of Drug Response Pathways in Humans , 2012, J. Comput. Biol..

[34]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[35]  Christopher G. Chute,et al.  The National Center for Biomedical Ontology , 2012, J. Am. Medical Informatics Assoc..

[36]  Lyle H. Ungar,et al.  Identifying potential adverse effects using the web: A new approach to medical hypothesis generation , 2011, J. Biomed. Informatics.

[37]  Russ B. Altman,et al.  A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports , 2012, J. Am. Medical Informatics Assoc..

[38]  Roded Sharan,et al.  PRINCIPLE: a tool for associating genes with diseases via network propagation , 2011, Bioinform..